Cover Image

ADRENAL CORTICAL CARCINOMA- A CASE REPORT

GUNASEELAN P PALANISAMY

Abstract


Adrenal cortical carcinoma is a rare endocrine neoplasm with a world wide incidence of two per million   population.There is a bimodal age distribution. Tumours may be functional or non functional depending on whether they produce cortisol , androgens , aldosterone or estrogen . The etiology of adrenal cortical carcinoma is unknown, although recent studies documenting chromosomal abnormalities and alterations in growth factor production have provided insight into possible mechanisms of molecular pthogenesis .           Associated with Li-Fraumani syndrome, MEN-1, Beckwith Wiedman syndrome and carney complex. Complete surgical resection is the curative therapy for localized adrenal cortical carcinoma. 65yrs old female patient presented with CO lower abdominal pain , abdominal swelling ,loss of weight loss of appetite.USG and CT showed Large, lobulated, heterogenous space occupying lesion in the region of left adrenal gland measuring 12 x8 x 7.5 cms and central necrosis is noted. We did open adrenalectomy . Histopathology report came as adrenal cortical carcinoma. In the past 5 years only two cases are reported in Rajiv Gandhi Government General Hospital, Chennai.

 


Full Text:

PDF

References


edited by Vincent T. DeVita, Samuel Hellman, Steven A. Rosenberg (2005).Cancer: principles & practice of oncology. Philadelphia: Lippincott-Raven.

Savarese, Diane MF; Lynnette K Nieman (2006-08-08). "Clinical presentation and evaluation of adrenocortical tumors". UpToDate Online v. 15.1. UpToDate. Retrieved 2007-06-05.

Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) (2002).Modern Surgical Pathology (2 Volume Set). London: W B Saunders.

Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrison'sPrinciples of Internal Medicine. New York: McGraw-Hill, 2005.

Kufe D (2000). Benedict RC, Holland JF, ed. Cancer medicine (5th ed.). Hamilton, Ont: B.C. Decker.

Laurence L. Brunton, editor-in-chief; John S. Lazo and Keith L. Parker, Associate Editors (2006).

Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th Edition. United States of America: The McGraw-Hill Companies, Inc.

Terzolo M, Angeli A, Fassnacht M et al. (June 2007). "Adjuvant mitotane treatment for adrenocortical carcinoma". N. Engl. J. Med. 356 (23): 2372–80.

http://www.firm-act.org

Allolio B, Fassnacht M (2006). "Clinical review: Adrenocortical carcinoma: clinical update". J Clin Endocrinol Metab 91 (6): 2027 –37.

The MD Anderson surgical oncology Handbook, fifth edition pg.no.533-536

Barnett CC, Varma DG, El-Naggar AK et al. Limitations of size in the evaluation of adrenal tumor.Surgery.2000;128:973-982.

Bornstein SR, Stratakis CA,Chrousos GP.Adrenocortical tumors:recent advances in basic concept and clinical management. Ann Intern Med.1999;130:759-771

Dackiw AP, Lee JE, Gagel RF,et al .Adrenal cortical carcinoma. World J Surg.2001;25:914-926.

Lee JE. Berger DH El-Naggar AK et al. Surgical management, DNA content and patient survival in adrenal cortical carcinoma. Surgery.1995;118:1090 .

Sasano H, Suzuki T, Moriya T. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol 2006;17:345-54.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University